•
Jun 30, 2019

Jazz Pharmaceuticals Q2 2019 Earnings Report

Total Revenue
$534M
Previous year: $500M
+6.7%
EPS
$4.05
Previous year: $3.49
+16.0%
Gross Profit
$506M
Previous year: $466M
+8.7%
Cash and Equivalents
$638M
Previous year: $485M
+31.5%
Free Cash Flow
$135M
Total Assets
$5.49B
Previous year: $5.35B
+2.6%

Jazz Pharmaceuticals

Jazz Pharmaceuticals